Methiodal
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Abrodil, Conturex, Kontrast U |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII |
|
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.348 |
Chemical and physical data | |
Formula | CH2INaO3S |
Molar mass | 243.98 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Methiodal is a pharmaceutical drug that was used as an iodinated contrast medium for X-ray imaging.[1] Its uses included myelography (imaging of the spinal cord); for this use, cases of adhesive arachnoiditis have been reported, similar to those seen under the contrast medium iofendylate.[2]
It is not known to be marketed anywhere in the world in 2021.[3]
References
[edit]- ^ Vällfors B, Hansson HA, Belghmaïdi M, Irstam L, Persson LI (September 1983). "Effect of radiologic contrast media and local anaesthetics on the blood-brain barrier and on the leptomeninges". Acta Neurologica Scandinavica. 68 (3): 164–70. doi:10.1111/j.1600-0404.1983.tb05343.x. PMID 6316706. S2CID 45152412.
- ^ Skalpe IO (March 1978). "Adhesive arachnoiditis following lumbar myelography". Spine. 3 (1): 61–4. doi:10.1097/00007632-197803000-00012. PMID 205956. S2CID 23788810.
- ^ "Methiodal search results". Drugs.com. Retrieved 2021-03-31.